Laura Brandolini

1.8k total citations
57 papers, 1.2k citations indexed

About

Laura Brandolini is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Laura Brandolini has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 17 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Laura Brandolini's work include Chemokine receptors and signaling (9 papers), Pain Mechanisms and Treatments (8 papers) and Multiple Myeloma Research and Treatments (5 papers). Laura Brandolini is often cited by papers focused on Chemokine receptors and signaling (9 papers), Pain Mechanisms and Treatments (8 papers) and Multiple Myeloma Research and Treatments (5 papers). Laura Brandolini collaborates with scholars based in Italy, United States and Brazil. Laura Brandolini's co-authors include Marcello Allegretti, Annamaria Cimini, Michele d’Angelo, Vanessa Castelli, Riccardo Bertini, Andrea Antonosante, Elisabetta Benedetti, Gianfranco Caselli, Andrea Aramini and Antonio Giordano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Laura Brandolini

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Brandolini Italy	22	329	327	326	229	126	57	1.2k
Roman V. Uzhachenko United States	17	200 0.6×	222 0.7×	370 1.1×	108 0.5×	82 0.7×	36	860
Ju Chen China	16	381 1.2×	297 0.9×	940 2.9×	107 0.5×	113 0.9×	64	1.7k
Deborah A. Sawatzky United Kingdom	10	127 0.4×	456 1.4×	400 1.2×	161 0.7×	143 1.1×	12	1.2k
Mourad Zerfaoui United States	22	469 1.4×	388 1.2×	633 1.9×	139 0.6×	140 1.1×	49	1.5k
Yu Ri Kim South Korea	25	256 0.8×	209 0.6×	521 1.6×	83 0.4×	108 0.9×	116	1.6k
Claudio Milanese Italy	22	189 0.6×	341 1.0×	287 0.9×	92 0.4×	78 0.6×	51	1.1k
Jing Yan China	19	159 0.5×	168 0.5×	604 1.9×	92 0.4×	192 1.5×	89	1.5k
Jing Luo China	22	242 0.7×	351 1.1×	642 2.0×	179 0.8×	155 1.2×	110	1.7k
Jai Youl Ro South Korea	24	108 0.3×	460 1.4×	516 1.6×	377 1.6×	227 1.8×	65	1.5k
Xiang Lin China	24	341 1.0×	552 1.7×	826 2.5×	343 1.5×	231 1.8×	108	2.4k

Countries citing papers authored by Laura Brandolini

Since Specialization

Citations

This map shows the geographic impact of Laura Brandolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Brandolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Brandolini more than expected).

Fields of papers citing papers by Laura Brandolini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Brandolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Brandolini. The network helps show where Laura Brandolini may publish in the future.

Co-authorship network of co-authors of Laura Brandolini

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Brandolini. A scholar is included among the top collaborators of Laura Brandolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Brandolini. Laura Brandolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Çarçak, Nihan, Canan Ulusoy, Erdem Tüzün, et al.. (2025). Reparixin as a Potential Antiepileptogenic Agent: Modulation of the CXCL1–CXCR1/2 Axis and Seizure Activity in a Kindling Rat Model of Temporal Lobe Epilepsy. International Journal of Molecular Sciences. 26(7). 2831–2831.

Catalani, Elisabetta, Nicla Romano, Marcello Ceci, et al.. (2025). A novel free fatty acid receptor agonist improving metabolic health in Drosophila models. Pharmacological Research. 216. 107769–107769.

Boccella, Serena, Francesca Guida, Iolanda Manzo, et al.. (2025). Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat. Diabetes & Metabolism Journal. 49(5). 990–1005. 1 indexed citations

Fousteri, Georgia, Meghan Jones, Rubina Novelli, et al.. (2025). Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes. Frontiers in Immunology. 16. 1576371–1576371.

Castelli, Vanessa, et al.. (2024). TNFα-CXCR1/2 partners in crime in insulin resistance conditions. Cell Death Discovery. 10(1). 486–486. 5 indexed citations

Rolesi, Rolando, Gaetano Paludetti, Pasquale Cocchiaro, et al.. (2024). Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss. British Journal of Pharmacology. 182(3). 546–563. 3 indexed citations

Castelli, Vanessa, Michele d’Angelo, Francesca Zazzeroni, et al.. (2023). Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice. Cell Death and Disease. 14(9). 605–605. 4 indexed citations

d’Angelo, Michele, Laura Brandolini, Mariano Catanesi, et al.. (2023). Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut. Cells. 12(5). 728–728. 8 indexed citations

Castelli, Vanessa, Laura Brandolini, Michele d’Angelo, et al.. (2021). CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling. Cells. 10(9). 2324–2324. 13 indexed citations

10.

Castelli, Vanessa, Antonella Paladini, Michele d’Angelo, et al.. (2021). Taurine and oxidative stress in retinal health and disease. CNS Neuroscience & Therapeutics. 27(4). 403–412. 61 indexed citations

11.

Catanesi, Mariano, Laura Brandolini, Michele d’Angelo, et al.. (2021). S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson’s Disease In Vitro Model. Biomedicines. 9(10). 1467–1467. 11 indexed citations

12.

Catanesi, Mariano, Laura Brandolini, Michele d’Angelo, et al.. (2021). L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson’s Disease. Antioxidants. 10(9). 1467–1467. 35 indexed citations

13.

Brandolini, Laura, Andrea Antonosante, Michela Bagnasco, et al.. (2020). NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes. Scientific Reports. 10(1). 18337–18337. 18 indexed citations

14.

Brandolini, Laura, Michele d’Angelo, Andrea Antonosante, Annamaria Cimini, & Marcello Allegretti. (2019). Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain. International Journal of Molecular Sciences. 20(12). 2904–2904. 77 indexed citations

15.

Beccari, Andrea R., Marica Gemei, Matteo Lo Monte, et al.. (2017). Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach. Scientific Reports. 7(1). 10999–10999. 26 indexed citations

16.

Lopes, Alexandre H., Laura Brandolini, Andrea Aramini, et al.. (2015). DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain. Pharmacological Research. 103. 69–79. 27 indexed citations

17.

Cimini, Annamaria, Laura Brandolini, Roberta Gentile, et al.. (2014). Gastroprotective Effects of L‐Lysine Salification of Ketoprofen in Ethanol‐Injured Gastric Mucosa. Journal of Cellular Physiology. 230(4). 813–820. 30 indexed citations

18.

Palea, Stéfano, et al.. (2013). DFL 14817, a new potent and selective TRPM8 antagonist for the treatment of urinary bladder disorders.. Neurourology and Urodynamics. 1 indexed citations

19.

Bizzarri, Cinzia, Sabrina Pagliei, Laura Brandolini, et al.. (2001). Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers 11Abbreviations: NSAIDs, non-steroidal anti-inflammatorydrugs; COX, cyclooxygenase; PG, prostaglandin; PMN, humanpolymorphonuclear leukocyte; IL-8, interleukin-8;[Ca2+]i, intracellular calcium concentration;MAPK, mitogen-activated protein kinases; fMLP,N-formyl-methionyl-leucyl-phenylalanine; ERK, extracellular signalregulated kinase; C5a, fifth component of complement; MCP-1, monocytechemotactic protein-1; NAP-2, neutrophil activating protein-2; GCP-2,granulocyte chemotactic peptide-2; PVP, polyvinylpyrrolidone; HBSS,Hank’s balanced salt solution; ENA-78, epithelial-derived neutrophilactivating protein-78; ECL, enhanced chemiluminescent; FURA-2AM;1-[2-(5-carboxyoxazol-2-yl)-6-amino-benzofuran-5-oxy]-2-(2′-amino-5′-ethlphenoxy)-ethane-N,N,N′,N′-tetraaceticacid pentaacetoxy methylester; MGSA/GRO, melanoma growth stimulatoryactivity/gene product of gro gene.. Biochemical Pharmacology. 61(11). 1429–1437. 32 indexed citations

20.

Brandolini, Laura, Gianfranco Caselli, Diana Boraschi, et al.. (1997). Interleukin-1 beta primes interleukin-8-stimulated chemotaxis and elastase release in human neutrophils via its type I receptor.. PubMed. 8(2). 173–8. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact